RCT – Page 18 – Communicable Diseases Research

Tocilizumab in the treatment of COVID-19-a meta-analysis

COVID-19의 치료에서 Tocilizumab - 메타 분석

Meta-Analysis

Published on 2021-11-052022-09-12
Journal: QJM: An International Journal of Medicine [Category] SARS, 진단,

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in healthy individuals: protocol for a systematic review and meta-analysis

건강한 개인의 불활성 SARS-COV-2 백신의 안전성 및 면역 원성 : 체계적인 검토 및 메타 분석을위한 프로토콜

Article

Published on 2021-11-052022-08-31
Journal: BMJ Open [Category] MERS, meta-analysis, SARS,

[키워드] abstracts Analysis approval assessment tool Bia clinical trial Cochrane Library collaboration conferences COVID-19 database Ethics evaluate evaluated event Grey literature healthy healthy individuals immunogenicity immunology in healthy individual inactivated inception infection control information Meta-analysis morbidity and mortality Patient peer-reviewed performed prevention of COVID-19 PROSPERO protocol provided randomised controlled trial Randomised controlled trials RCT RCTs registration number required Research review Safety SARS-CoV-2 vaccine Spread Stage statistical analysis systematic review tested Web of Science
[DOI] 10.1136/bmjopen-2021-056106 PMC 바로가기 [Article Type] Article

Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions

말라리아 및 비 말라리아 조건에 대한 무작위 대조 시험에서 클로로퀸 및 하이드 록시 클로로 퀴인의 안전성에 대한 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2021-11-042022-09-10
Journal: Systematic Reviews [Category] SARS, 임상,

[키워드] 95% confidence interval adverse effects adverse event applied assessment cardiac complication Cardiac complications CENTRAL certainty certainty of evidence Chloroquine clinical trials condition conditions coronavirus coronavirus disease COVID-19 development Effectiveness evaluate event rate event rates frequencies Frequency HCQ Hydroxychloroquine incidence increase LILACS low frequency malarial management meta-analyses Meta-analysis moderate no significant difference objective Odds ratio Participants patients with COVID-19 Placebo Primary outcome Primary outcomes random-effects model randomized clinical trial Randomized controlled trial RCT RCTs remained Result retinopathy SAE SAEs Safety Serious Adverse Event Serious Adverse Events supplementary material systematic review trials were excluded
[DOI] 10.1186/s13643-021-01835-x PMC 바로가기 [Article Type] Meta-Analysis

Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: systematic review and meta-analysis

IL-6 수용체 길항제로 치료받은 COVID-19 환자의 사망률 감소 및 부작용 증가 : 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2021-11-022022-09-01
Journal: Scientific Reports [Category] MERS, SARS, 임상, 진단, 치료법,

[키워드] 1.26 antagonist antagonists baseline Cochrane Library COVID-19 COVID-19 patient COVID-19 patients database Decreased effective Epidemiology ICU IL-6 IL-6 receptor Immunotherapy impaired liver function Infectious diseases lower mortality mechanical ventilation Meta-analysis Mortality mortality risk neutropenia Patient patients hospitalized patients treated PMC PubMed Central random effect RCT receptor reducing mortality Research retrieved risk risk difference risk ratio Secondary infection secondary infections Side effect Side effects systematic review treated treating COVID-19 patients unique viral infection WHO
[DOI] 10.1038/s41598-021-00726-4 PMC 바로가기 [Article Type] Meta-Analysis

Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: a protocol of a META-epidemiological study

COVID-19에 대한 약리학 적 치료의 무작위 대조 시험에서보고 된 환자의 중요한 결과 : 메타-여혈 연구의 프로토콜

Protocol

Published on 2021-11-012022-09-10
Journal: Systematic Reviews [Category] MERS, SARS, 임상,

[키워드] Abstract applicability association blood product Care Characteristics Chinese Clinical research controlled trials coronavirus coronavirus disease COVID-19 database deficiency defined Descriptive statistics functional Health Health care help include information investigator investigators lead likelihood morbidity Mortality multivariable analysis NMA open Open Science Framework outcome outcomes pandemic Patient-important outcome patients pharmacologic treatment pharmacological pharmacological treatment prevention professional Prophylaxis proportion protocol Randomized controlled trial RCT RCTs reported Reporting Research researcher risk supplementary material therapy Treatment Trial univariable WHO
[DOI] 10.1186/s13643-021-01838-8 PMC 바로가기 [Article Type] Protocol

Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials

야누스 키나제 억제제와 코로나19 주요 결과: 야누스의 두 얼굴을 잊어야 할 때! 무작위 대조 시험의 메타 분석

Meta-Analysis

Published on 2021-11-012022-09-11
Journal: Clinical Rheumatology [Category] SARS, 임상,

[키워드] added Adult patients antibody production assigned Baricitinib benefit concerning coronavirus disease coronavirus disease-2019 COVID-19 COVID-19 infection Cytokine storm database death disease ECMO Efficacy Endpoint ENhance evaluate extracorporeal membrane oxygenation global public health In-hospital Inflammatory response inhibitor Jak JAK inhibitor jak inhibitors janus Janus kinase Janus kinase inhibitor Kinase inhibitor Mechanical mechanical ventilation mechanism Meta-analysis Mortality nezulcitinib nightmare outcome outcomes pathophysiologic Patient patients with COVID-19 Randomized controlled trial Randomized controlled trials RCT RCTs reduction in risk risk reduction ruxolitinib searched significant decrease stages Standard of care subject Tofacitinib Treatment
[DOI] 10.1007/s10067-021-05884-4 PMC 바로가기 [Article Type] Meta-Analysis

Sex and Gender in COVID-19 Vaccine Research: Substantial Evidence Gaps Remain

Global Women's Health

Published on 2021-11-012022-10-31
Journal: Frontiers in Global Women's Health [Category] COVID-19,

Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis

소설 코로나 바이러스 질병 (COVID-19)에 대한 기존의 서양 의학 치료와 결합 된 한약의 기여, 체계적인 검토 및 메타 분석을 통한 현재의 증거

Review

Published on 2021-11-012022-08-31
Journal: Phytotherapy research : PTR [Category] MERS, SARS, 치료제,

[키워드] approach assessment case-control studies case-control study Chest CT Chinese Clinical symptoms clinical trial Cohort studies cohort study Controlled trial cough COVID-19 COVID-19 patients database development Disease progression effective Efficacy and safety Evidence fatigue Fever integrative medicine Meta-analysis moderate Newcastle-Ottawa Scale NOS novel coronavirus disease observational studies observational study patients potential treatment option preventing disease progression provide Randomized controlled trials RCT RCTs required review risk of bia searched systematic review TCM the Newcastle-Ottawa Scale Traditional Chinese medicine treating COVID-19 Treatment treatment for COVID-19 was used
[DOI] 10.1002/ptr.7209 PMC 바로가기 [Article Type] Review

Abstracts for reports of randomized trials of COVID-19 interventions had low quality and high spin

Research article

Published on 2021-11-012022-10-05
Journal: Journal of clinical epidemiology [Category] 임상,

Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality

COVID-19 관리 및 예방에 대한 임상 시험: 방법론적 질을 검토하는 메타 역학 연구

Article

Published on 2021-11-012022-09-11
Journal: Journal of clinical epidemiology [Category] 임상,